
Sign up to save your podcasts
Or


In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
By J.P. Morgan Asset Management4.1
8989 ratings
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.

967 Listeners

194 Listeners

97 Listeners

801 Listeners

291 Listeners

85 Listeners

256 Listeners

185 Listeners

59 Listeners

1,297 Listeners

76 Listeners

430 Listeners

27 Listeners

80 Listeners

25 Listeners